No Data
No Data
Inovio Pharmaceuticals Inc. Stock Rallies 10.7%, Outperforms Competitors
The FDA has suffered a severe blow as the Trump administration cuts positions in public health institutions, leading to a decline in stock prices of pharmaceutical industry companies.
On Tuesday, the Trump administration began a large-scale reduction of positions at USA public health Institutions.
Cantor Analyst rarely criticized the USA Secretary of Health, stating that "misguided decisions will backfire on the government's reputation," causing the Biotechnology Sector to plummet.
The financial services institution Cantor Fitzgerald's Biotechnology Analysts Josh Schimmer and Eric Schmidt rarely publicly criticized the leadership of USA Health Secretary Kennedy.
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Sector Update: Health Care
Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief